Treatment of Benzodiazepine Withdrawal Symptoms
Benzodiazepines are the treatment of choice for managing benzodiazepine withdrawal symptoms, using a gradual taper protocol rather than abrupt discontinuation, as abrupt cessation can cause seizures and death. 1, 2
Critical Safety Framework
Never discontinue benzodiazepines abruptly—this can cause life-threatening seizures, delirium, and death, making it as dangerous as suddenly stopping antihypertensives in a hypertensive crisis. 2 Benzodiazepine withdrawal carries significantly higher risks than opioid withdrawal and must always be managed with extreme caution. 2
- If a patient is taking both opioids and benzodiazepines, taper the benzodiazepine first due to the higher mortality risk associated with benzodiazepine withdrawal. 2
- Withdrawal seizures have been reported even with therapeutic doses used for as little as 15 days, though they are more common with long-term high-dose use. 3
Recommended Tapering Protocol
Reduce the benzodiazepine dose by 10-25% of the current dose (not the original dose) every 1-2 weeks for patients on benzodiazepines less than 1 year. 2 This percentage-based reduction prevents disproportionately large final decrements that occur with straight-line reductions. 2
For patients on benzodiazepines longer than 1 year, slow the taper to 10% of the current dose per month. 2 The entire process will likely require a minimum of 6-12 months, and possibly longer. 2
Specific Tapering Approach:
- The taper rate must be determined by the patient's tolerance to withdrawal symptoms, not by a rigid schedule. 2 Pauses in the taper are acceptable and often necessary when withdrawal symptoms emerge. 2
- Reductions should always be calculated as a percentage of the current dose at each step. 2
- Example for a patient on diazepam 20 mg/day: reduce to 15 mg/day (25% reduction) for weeks 1-2, then to 11-12 mg/day (20-25% of 15 mg) for weeks 3-4, continuing this pattern. 2
Choice of Benzodiazepine for Tapering
Long-acting benzodiazepines like diazepam or chlordiazepoxide provide superior protection against seizures and delirium during withdrawal. 2 Diazepam is particularly convenient due to available dosage strengths. 4
Important exceptions:
- In elderly patients or those with hepatic dysfunction, use short/intermediate-acting agents like lorazepam or oxazepam instead, as they are safer despite providing less seizure protection. 2
- For alprazolam specifically, taper at 0.25 mg reductions every 1-2 weeks regardless of dose, as triazolobenzodiazepines require special consideration. 2, 5
Monitoring Withdrawal Symptoms
Follow up at least monthly during the taper, with more frequent contact during difficult phases. 2 Monitor specifically for:
- Neurological symptoms: Anxiety, tremor, hyperreflexia, seizures (most critical), confusion, altered mental status 2
- Autonomic symptoms: Insomnia, sweating, tachycardia, headache 2
- Somatic symptoms: Muscle aches, muscle cramps, weakness, nausea, vomiting 2
- Perceptual disturbances: Hypersensitivity to stimuli, tinnitus 6
- Psychiatric symptoms: Depression, panic attacks, dysphoria, anhedonia 2
Clinically significant withdrawal symptoms signal the need to slow or pause the taper immediately. 2 Some patients may need to extend their taper over many months to years to avoid debilitating symptoms. 6
Adjunctive Pharmacological Support
Gabapentin can mitigate withdrawal symptoms during tapering. 2 Start with 100-300 mg at bedtime or three times daily, increasing by 100-300 mg every 1-7 days as tolerated. 2 Adjust dosing in patients with renal insufficiency. 2
Other adjunctive medications with evidence:
- Carbamazepine 400 mg twice daily may assist discontinuation and prevent seizures, though it can affect alprazolam metabolism. 2, 7
- Pregabalin has shown potential benefit in facilitating tapering. 2
- SSRIs (particularly paroxetine) may help manage underlying anxiety during the taper. 2
For specific withdrawal symptoms:
- Trazodone 25-200 mg for insomnia (short-term use). 2
- NSAIDs or acetaminophen for muscle aches. 2
- Antiemetics for nausea. 2
Essential Non-Pharmacological Support
Cognitive-behavioral therapy (CBT) during the taper significantly increases success rates and should be incorporated whenever possible. 2, 4 This is one of the most evidence-based interventions for improving outcomes. 2
Additional supportive measures include: 2, 4
- Patient education about benzodiazepine risks and the temporary nature of withdrawal symptoms
- Mindfulness and relaxation techniques
- Sleep hygiene education
- Problem-solving therapy
- Exercise and fitness training
When to Refer to a Specialist Immediately
Refer to a specialist for: 2
- History of withdrawal seizures
- Unstable psychiatric comorbidities
- Co-occurring substance use disorders
- Previous unsuccessful office-based tapering attempts
- High-dose benzodiazepine dependence (>40 mg diazepam equivalent daily for >8 months) 5
Critical Pitfalls to Avoid
- Never use straight-line percentage reductions from the starting dose—this creates disproportionately large final reductions that patients cannot tolerate. 2
- Never abandon the patient even if tapering is unsuccessful—maintain the therapeutic relationship and consider maintenance therapy. 2
- Never substitute another benzodiazepine or Z-drug (zolpidem, zaleplon) in elderly patients—these carry similar risks. 2
- Never discharge patients before withdrawal peaks, especially with long-acting agents—diazepam withdrawal peaks at days 5-12, chlordiazepoxide as late as day 21. 2
Special Populations
Elderly patients: Use lower doses, more gradual tapers, and preferably short-acting agents due to increased risks of cognitive impairment, falls, fractures, and loss of functional independence. 2
Pregnant patients: Do not taper during pregnancy without specialist consultation, as withdrawal can cause spontaneous abortion and premature labor. 2
Patients with hepatic dysfunction: Prefer lorazepam or oxazepam over diazepam. 2
Expected Outcomes
Successful withdrawal typically results in improved psychomotor and cognitive functioning, particularly in memory and daytime alertness. 2 However, around half of patients may temporarily resume benzodiazepines, and some may need other psychotropic medication. 4 The goal is durability of the taper, not speed. 2